Systems designed to meet the demands of modern industries—addressing environmental challenges, enhancing work safety, and delivering proven, cost-effective technologies. Built on decades of expertise, these practical, forward-thinking approaches support a healthier planet and safer workplaces.
The Mobile Destruction Unit efficiently manages exhaled Nitrous Oxide (N2O), and ensures a safer environment for healthcare professionals while significantly reducing environmental impact.
The Recycling Decomposition Unit represents an intelligent solution that effectively collects Nitrous Oxide (N2O) from discarded N2O bottles and decomposes it within a self-supporting system with minimal energy consumption and low noise output.
N2O emissions are harmful to the work environment and the climate. Would you like to know how you can minimise the emissions at your workplace? Use our calculator to find out.
Hospitals rely on Nitrous Oxide for medical procedures, but improper handling contributes to greenhouse gas emissions and staff exposure. Medclair’s systems capture and decompose Nitrous Oxide, enhancing safety while reducing environmental impact.
In healthcare settings, N2O is always mixed with Oxygen to ensure safe administration. The gas can be delivered as a pre-mixed solution or blended with Oxygen during patient care. Administration occurs through a mask, which may include a face mask (single or double), a mouthpiece, or, in dental settings, a nasal mask.
Exposure to N2O can pose several health hazards, especially in occupational settings where prolonged or repeated exposure occurs. The risks depend on factors such as the concentration of N2O, the duration of exposure, and the implementation of appropriate safety measures.
In healthcare, it plays a key role in anesthesia and pain management. When mixed with Oxygen, it serves as a mild sedative and analgesic, providing effective pain relief, reducing stress, and alleviating anxiety during medical and dental procedures. Compared to other anesthetic gases, N2O is stands out for its rapid onset, low-risk profile, and cost-effectiveness.
Founded in 2013, Medclair is an award-winning Swedish cleantech company with global ambitions, united by a shared purpose: to minimise our climate impact while safeguarding the workplace environment related to Nitrous Oxide (N2O) emissions. Today, our products are distributed in over 20 countries, reflecting our strong global presence.
Suez and Medclair inaugurated an industrial pilot plant in Vaucluse, France, using Medclair’s technology to safely decompose hazardous nitrous oxide cylinders. The facility marks a collaboration to address waste management challenges in the region. Medclair’s solution enables controlled breakdown of cylinders, reducing environmental risks.
Medclair partners with SUEZ to integrate its technology into waste-sorting systems, enabling a scalable solution for reducing industrial hazards. The collaboration supports circular economy goals by improving waste management processes. ICI, the digital platform for France’s public service broadcasters France Bleu and France 3, highlights the innovation in its coverage.
Medclair and SUEZ’s joint initiative uses advanced gas mitigation technology to safely capture and decompose discarded nitrous oxide canisters. The collaboration reduces workplace hazards for plant personnel while addressing climate impact. Radio France’s France Inter featured the project as part of a national media segment.
Hvidovre Hospital in Denmark showcases its sustainable healthcare initiatives during the 6th Conference of Sustainable Healthcare. The hospital highlights the use of CDU and MDU machines as part of efforts to cut CO₂ emissions. Representatives will discuss these solutions and broader sustainability strategies.
Medclair teams up with DeSpray Environmental to strengthen its recycling operations. The collaboration targets expansion in the EU and North America, leveraging DeSpray’s expertise within the Osse Equipment Manufacturing Group. Both companies aim to enhance sustainable recycling solutions through this global partnership.
Beacon Madaes holds the exclusive rights to distribute Medclair’s Nitrous Oxide Detector in a newly announced deal. The agreement positions Beacon Madaes as the sole distributor for the device, which detects nitrous oxide—a key tool for healthcare safety. Medclair’s product targets medical and industrial settings where gas monitoring is critical.
Medclair
Medclair makes technology that breaks nitrous oxide into nitrogen and oxygen for hospitals using it in medical procedures.